Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics

May 2013 | 43 pages | ID: C72AEE21B75EN
La Merie Publishing

Abstracts

The Competitive Intelligence Report Human Papilloma Virus (HPV) Vaccines & Therapeutics as of May 2013 provides a competitor analysis in the product portfolios and development pipelines of novel vaccines and therapeutics for prophylaxis of HPV infection and HPV-induced neoplasias and treatment of HPV-induced warts and neoplasias. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report provides information on the marketed HPV vaccines with market size and includes a compilation of current active projects in research and development of novel HPV vaccines and therapeutics. In addition, the report lists company-specific product portfolios and R&D pipelines of HPV vaccines and therapeutics. Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Contents

• 2012 Sales of HPV vaccines
• HPV Vaccines
• HPV Therapeutics